These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Usefulness and limitations of murine tumor models for the identification of new antitumor agents. Goldin A; Johnson RK; Venditti JM Antibiot Chemother (1971); 1980; 28():1-7. PubMed ID: 6998358 [TBL] [Abstract][Full Text] [Related]
6. The choice of animal tumors for experimental studies of cancer therapy. Hewitt HB Adv Cancer Res; 1978; 27():149-200. PubMed ID: 356543 [No Abstract] [Full Text] [Related]
8. Host-tumor-drug interrelationships in the tumorous murine model. Goldin A Adv Enzyme Regul; 1980; 18():323-34. PubMed ID: 7446302 [No Abstract] [Full Text] [Related]
9. Tumor models for preclinical development of targeted agents. Teicher BA Prog Drug Res; 2005; 63():43-66. PubMed ID: 16265876 [No Abstract] [Full Text] [Related]
10. Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo. Twentyman PR Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1213-20. PubMed ID: 528265 [No Abstract] [Full Text] [Related]
11. [Chemosensitivity predictive tests: current status and future applications in chemotherapy of gastrointestinal cancers (author's transl)]. Ballet F; Poupon R; Petit J; Darnis F Gastroenterol Clin Biol; 1982 Feb; 6(2):192-201. PubMed ID: 7060865 [No Abstract] [Full Text] [Related]
12. A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development. Rocchetti M; Poggesi I; Germani M; Fiorentini F; Pellizzoni C; Zugnoni P; Pesenti E; Simeoni M; De Nicolao G Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):265-8. PubMed ID: 15733231 [No Abstract] [Full Text] [Related]
14. The limitations of model systems in prostatic cancer. Handelsman H Oncology; 1977; 34(3):96-9. PubMed ID: 917445 [TBL] [Abstract][Full Text] [Related]
15. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostate adenocarcinoma into congenitally athymic (nude) mice. I. Hormone dependency and histopathology. Drago JR; Gershwin ME; Maurer RE; Ikeda RM; Eckels DD J Natl Cancer Inst; 1979 Apr; 62(4):1057-66. PubMed ID: 285279 [No Abstract] [Full Text] [Related]
16. In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency. Warenius HM; Bleehen NM Br J Cancer; 1982 Jul; 46(1):45-50. PubMed ID: 7104196 [TBL] [Abstract][Full Text] [Related]
18. Metaplasia and progressive growth of heterologous tumor transplants in the subcutaneous space of mice. Greene HS; Harvey EK Am J Pathol; 1968 Aug; 53(2):293-313. PubMed ID: 5667581 [No Abstract] [Full Text] [Related]
19. Commentary: screening for anti-cancer agents; the relative merits of in vitro and in vovo techniques. Connors TA; Phillips BJ Biochem Pharmacol; 1975 Dec; 24(24):2217-24. PubMed ID: 1218096 [No Abstract] [Full Text] [Related]
20. Actions of hyperthermia on tumour cells cultured in vitro. Giovanella BC Recent Results Cancer Res; 1977; (59):36-42. PubMed ID: 331416 [No Abstract] [Full Text] [Related] [Next] [New Search]